{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:08:47Z","timestamp":1751429327158,"version":"3.41.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"DOI":"10.7759\/cureus.87084","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:06:09Z","timestamp":1751357169000},"source":"Crossref","is-referenced-by-count":0,"title":["Fatal SARS-CoV-2 Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia"],"prefix":"10.7759","author":[{"given":"Yuri","family":"Furuyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Suwabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hodaka","family":"Yonezawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Katagiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Fuse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Shibasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ushiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohito","family":"Sone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Masuko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.09.002","article-title":"Revised guidelines for coronavirus disease 19 management in hematopoietic cell transplantation and cellular therapy recipients (August 2022)","volume":"28","author":"Dioverti V","year":"2022","unstructured":"Dioverti V, Boghdadly ZE, Shahid Z, et al.. Revised guidelines for coronavirus disease 19 management in hematopoietic cell transplantation and cellular therapy recipients (August 2022). Transplant Cell Ther. 2022, 28:810-21. 10.1016\/j.jtct.2022.09.002","journal-title":"Transplant Cell Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00815-0","article-title":"Persistent SARS-CoV-2 infection: significance and implications","volume":"24","author":"Machkovech HM","year":"2024","unstructured":"Machkovech HM, Hahn AM, Garonzik Wang J, et al.. Persistent SARS-CoV-2 infection: significance and implications. Lancet Infect Dis. 2024, 24:e453-62. 10.1016\/S1473-3099(23)00815-0","journal-title":"Lancet Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.03.010","article-title":"High mortality of COVID-19 early after allogeneic stem cell transplantation: a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group","volume":"28","author":"Schaffrath J","year":"2022","unstructured":"Schaffrath J, Brummer C, Wolff D, et al.. High mortality of COVID-19 early after allogeneic stem cell transplantation: a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group. Transplant Cell Ther. 2022, 28:337.e1-10. 10.1016\/j.jtct.2022.03.010","journal-title":"Transplant Cell Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-024-02304-4","article-title":"Are any specific respiratory viruses more severe than others in recipients of allogeneic stem cell transplantation? A focus on lower respiratory tract disease","volume":"59","author":"P\u00e9rez A","year":"2024","unstructured":"P\u00e9rez A, G\u00f3mez D, Montoro J, et al.. Are any specific respiratory viruses more severe than others in recipients of allogeneic stem cell transplantation? A focus on lower respiratory tract disease. Bone Marrow Transplant. 2024, 59:1118-26. 10.1038\/s41409-024-02304-4","journal-title":"Bone Marrow Transplant"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2217\/fvl.11.21","article-title":"Virus reactivation: a panoramic view in human infections","volume":"6","author":"Traylen CM","year":"2011","unstructured":"Traylen CM, Patel HR, Fondaw W, et al.. Virus reactivation: a panoramic view in human infections. Future Virol. 2011, 6:451-63. 10.2217\/fvl.11.21","journal-title":"Future Virol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/path.6035","article-title":"Persistent SARS-CoV-2 infection in patients seemingly recovered from COVID-19","volume":"259","author":"Bussani R","year":"2023","unstructured":"Bussani R, Zentilin L, Correa R, et al.. Persistent SARS-CoV-2 infection in patients seemingly recovered from COVID-19. J Pathol. 2023, 259:254-63. 10.1002\/path.6035","journal-title":"J Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07029-4","article-title":"Prevalence of persistent SARS-CoV-2 in a large community surveillance study","volume":"626","author":"Ghafari M","year":"2024","unstructured":"Ghafari M, Hall M, Golubchik T, et al.. Prevalence of persistent SARS-CoV-2 in a large community surveillance study. Nature. 2024, 626:1094-101. 10.1038\/s41586-024-07029-4","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.922431","article-title":"Daily, self-test rapid antigen test to assess SARS-CoV-2 viability in de-isolation of patients with COVID-19","volume":"9","author":"Bae S","year":"2022","unstructured":"Bae S, Park H, Kim JY, et al.. Daily, self-test rapid antigen test to assess SARS-CoV-2 viability in de-isolation of patients with COVID-19. Front Med (Lausanne). 2022, 9:922431. 10.3389\/fmed.2022.922431","journal-title":"Front Med (Lausanne)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0258970","article-title":"Clinical characteristics and viral load dynamics of COVID-19 in a mildly or moderately symptomatic outpatient sample","volume":"16","author":"Caplan A","year":"2021","unstructured":"Caplan A, Bates KW, Brioni C, et al.. Clinical characteristics and viral load dynamics of COVID-19 in a mildly or moderately symptomatic outpatient sample. PLoS One. 2021, 16:e0258970. 10.1371\/journal.pone.0258970","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-023-02039-2","article-title":"Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab","volume":"51","author":"Franceschini E","year":"2023","unstructured":"Franceschini E, Pellegrino M, Todisco V, et al.. Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab. Infection. 2023, 51:1577-81. 10.1007\/s15010-023-02039-2","journal-title":"Infection"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000028470","article-title":"Prolonged viral positivity induced recurrent coronavirus disease 2019 (COVID-19) pneumonia in patients receiving anti-CD20 monoclonal antibody treatment: case reports","volume":"100","author":"Deveci B","year":"2021","unstructured":"Deveci B, Saba R. Prolonged viral positivity induced recurrent coronavirus disease 2019 (COVID-19) pneumonia in patients receiving anti-CD20 monoclonal antibody treatment: case reports. Medicine (Baltimore). 2021, 100:e28470. 10.1097\/MD.0000000000028470","journal-title":"Medicine (Baltimore)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/cells11172743","article-title":"Immune determinants of viral clearance in hospitalised COVID-19 patients: Reduced circulating na\u00efve CD4+ T cell counts correspond with delayed viral clearance","volume":"11","author":"Zlei M","year":"2022","unstructured":"Zlei M, Sidorov IA, Joosten SA, et al.. Immune determinants of viral clearance in hospitalised COVID-19 patients: Reduced circulating na\u00efve CD4+ T cell counts correspond with delayed viral clearance. Cells. 2022, 11:10.3390\/cells11172743","journal-title":"Cells"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-021-01020-0","article-title":"Possible reactivation of SARS-CoV-2 in a patient with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: a case report","volume":"3","author":"Dalla Via V","year":"2021","unstructured":"Dalla Via V, von Rotz M, B\u00e4ttig V, et al.. Possible reactivation of SARS-CoV-2 in a patient with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: a case report. SN Compr Clin Med. 2021, 3:2011-5. 10.1007\/s42399-021-01020-0","journal-title":"SN Compr Clin Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.17000","article-title":"Severe relapse of SARS-CoV-2 infection in a kidney transplant recipient with negative nasopharyngeal SARS-CoV-2 RT-PCR after rituximab","volume":"22","author":"Morel A","year":"2022","unstructured":"Morel A, Imbeaud S, Scemla A, et al.. Severe relapse of SARS-CoV-2 infection in a kidney transplant recipient with negative nasopharyngeal SARS-CoV-2 RT-PCR after rituximab. Am J Transplant. 2022, 22:2099-103. 10.1111\/ajt.17000","journal-title":"Am J Transplant"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00968-1","article-title":"Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia","volume":"13","author":"Lancman G","year":"2020","unstructured":"Lancman G, Mascarenhas J, Bar-Natan M. Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia. J Hematol Oncol. 2020, 13:131. 10.1186\/s13045-020-00968-1","journal-title":"J Hematol Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.03.001","article-title":"Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation","volume":"80","author":"Ye G","year":"2020","unstructured":"Ye G, Pan Z, Pan Y, et al.. Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation. J Infect. 2020, 80:e14-7. 10.1016\/j.jinf.2020.03.001","journal-title":"J Infect"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.569381","article-title":"Viral infections in HSCT: detection, monitoring, clinical management, and immunologic implications","volume":"11","author":"Annaloro C","year":"2020","unstructured":"Annaloro C, Serpenti F, Saporiti G, et al.. Viral infections in HSCT: detection, monitoring, clinical management, and immunologic implications. Front Immunol. 2020, 11:569381. 10.3389\/fimmu.2020.569381","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251214","article-title":"Evaluation of potential COVID-19 recurrence in patients with late repeat positive SARS-CoV-2 testing","volume":"16","author":"Peltan ID","year":"2021","unstructured":"Peltan ID, Beesley SJ, Webb BJ, Lopansri BK, Sinclair W, Jacobs JR, Brown SM. Evaluation of potential COVID-19 recurrence in patients with late repeat positive SARS-CoV-2 testing. PLoS One. 2021, 16:e0251214. 10.1371\/journal.pone.0251214","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.11.033","article-title":"SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis","volume":"184","author":"Wendisch D","year":"2021","unstructured":"Wendisch D, Dietrich O, Mari T, et al.. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell. 2021, 184:6243-61.e27. 10.1016\/j.cell.2021.11.033","journal-title":"Cell"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.15300","article-title":"Application of CMV-IVIg as prophylaxis against cytomegalovirus reactivation in allogeneic hematopoietic stem cell transplantation patients","volume":"38","author":"Cui J","year":"2024","unstructured":"Cui J, Zhou Y, Zhao K, et al.. Application of CMV-IVIg as prophylaxis against cytomegalovirus reactivation in allogeneic hematopoietic stem cell transplantation patients. Clin Transplant. 2024, 38:e15300. 10.1111\/ctr.15300","journal-title":"Clin Transplant"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2010.03400.x","article-title":"Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients","volume":"11","author":"Jordan SC","year":"2011","unstructured":"Jordan SC, Toyoda M, Kahwaji J, Vo AA. Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients. Am J Transplant. 2011, 11:196-202. 10.1111\/j.1600-6143.2010.03400.x","journal-title":"Am J Transplant"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020202504","article-title":"Review of the chest CT differential diagnosis of ground-glass opacities in the COVID era","volume":"297","author":"Parekh M","year":"2020","unstructured":"Parekh M, Donuru A, Balasubramanya R, Kapur S. Review of the chest CT differential diagnosis of ground-glass opacities in the COVID era. Radiology. 2020, 297:E289-302. 10.1148\/radiol.2020202504","journal-title":"Radiology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-021-01120-w","article-title":"Ground-glass opacity (GGO): a review of the differential diagnosis in the era of COVID-19","volume":"39","author":"Cozzi D","year":"2021","unstructured":"Cozzi D, Cavigli E, Moroni C, Smorchkova O, Zantonelli G, Pradella S, Miele V. Ground-glass opacity (GGO): a review of the differential diagnosis in the era of COVID-19. Jpn J Radiol. 2021, 39:721-32. 10.1007\/s11604-021-01120-w","journal-title":"Jpn J Radiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.03.015","article-title":"Noninfectious pulmonary toxicity after allogeneic hematopoietic cell transplantation","volume":"28","author":"Patel SS","year":"2022","unstructured":"Patel SS, Ahn KW, Khanal M, et al.. Noninfectious pulmonary toxicity after allogeneic hematopoietic cell transplantation. Transplant Cell Ther. 2022, 28:310-20. 10.1016\/j.jtct.2022.03.015","journal-title":"Transplant Cell Ther"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00327-0","article-title":"Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study","volume":"399","author":"Menni C","year":"2022","unstructured":"Menni C, Valdes AM, Polidori L, et al.. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet. 2022, 399:1618-24. 10.1016\/S0140-6736(22)00327-0","journal-title":"Lancet"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01302-5","article-title":"COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey","volume":"35","author":"Ljungman P","year":"2021","unstructured":"Ljungman P, de la Camara R, Mikulska M, et al.. COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey. Leukemia. 2021, 35:2885-94. 10.1038\/s41375-021-01302-5","journal-title":"Leukemia"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16020379","article-title":"COVID-19 outcomes in patients with hematologic malignancies in the era of COVID-19 vaccination and the Omicron variant","volume":"16","author":"Mart\u00ednez-L\u00f3pez J","year":"2024","unstructured":"Mart\u00ednez-L\u00f3pez J, de la Cruz J, Gil-Manso R, et al.. COVID-19 outcomes in patients with hematologic malignancies in the era of COVID-19 vaccination and the Omicron variant. Cancers (Basel). 2024, 16:10.3390\/cancers16020379","journal-title":"Cancers (Basel)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.984376","article-title":"Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience","volume":"13","author":"Shields AM","year":"2022","unstructured":"Shields AM, Tadros S, Al-Hakim A, et al.. Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience. Front Immunol. 2022, 13:984376. 10.3389\/fimmu.2022.984376","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/372776-fatal-sars-cov-2-reactivation-after-allogeneic-hematopoietic-stem-cell-transplantation-for-severe-aplastic-anemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:06:10Z","timestamp":1751357170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/372776-fatal-sars-cov-2-reactivation-after-allogeneic-hematopoietic-stem-cell-transplantation-for-severe-aplastic-anemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.87084","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,1]]}}}